| An update on gene therapy programs. | |
| | |
MedLine Citation:
|
PMID: 19890502 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
This commentary discusses the most significant advances that were presented at the 12th Annual Meeting of the American Society of Gene Therapy. Many reports focused on clinical trials for the treatment of cancer and other pathological conditions, preclinical studies for various diseases, genetic immunization protocols and improvement of vector design. In this respect, a major emphasis was placed on safety issues. |
| | |
Authors:
|
Gaetano Romano |
Publication Detail:
|
Type: Congresses |
Journal Detail:
|
Title: Drug news & perspectives Volume: 22 ISSN: 0214-0934 ISO Abbreviation: Drug News Perspect. Publication Date: 2009 Sep |
Date Detail:
|
Created Date: 2009-11-05 Completed Date: 2010-01-19 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8809164 Medline TA: Drug News Perspect Country: Spain |
Other Details:
|
Languages: eng Pagination: 435-40 Citation Subset: IM |
Copyright Information:
|
Copyright 2009 Prous Science, S.A.U. or its licensors. All rights reserved. |
Affiliation:
|
College of Science and Technology, Temple University, Philadelphia, USA. gromano@temple.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adenoviridae
/
genetics Animals Blindness / genetics, therapy Clinical Trials as Topic Gene Therapy* Genetic Vectors Humans Neoplasms / therapy Parkinson Disease / genetics, therapy |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A report on the 69th Annual Meeting of the Society for Investigative Dermatology.
Next Document: Clathrate hydrates with hydrogen-bonding guests.